C4 Therapeutics

C4 Therapeutics Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

C4 Therapeutics key operating metrics including Pre-Clinical Development Phase Products, environmental, and social and governance score (ESG).

Pre-Clinical Development Phase Products

Q2, 2020

Discovery Phase Products

Q2, 2020

Patents (US)

Q2, 2020

Operating Metrics

Metrics	Q2, 2020
Pre-Clinical Development Phase Products	2
Discovery Phase Products	2
Patents (US)	2
Patent Applications (US)	10
Patent Applications (Foreign)	22
Patent Applications (Patent Cooperation Treaty)	7
Co-Owned Patent Applications (US)	5
Co-Owned Patent Applications (Foreign)	3
Co-Owned Patent Applications (Patent Cooperation Treaty)	2

40-49 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Source:CSRHub